What is leprsoy?
Symptoms:
Leprosy typically manifests as skin lesions, which may vary depending on the type of the disease:
- Tuberculoid leprosy:
- Well-defined, pale or reddish skin patches with loss of sensation
- Dryness and atrophy of the skin
- Nerve damage, leading to muscle weakness and numbness
- Lepromatous leprosy:
- Multiple, symmetrical skin lesions with infiltration and thickening
- Diffuse granulomatous involvement of the skin, leading to a waxy appearance
- Involvement of the mucous membranes and internal organs
- Borderline leprosy:
- Intermediate characteristics of tuberculoid and lepromatous leprosy
- Indeterminate leprosy:
- Early stage of the disease with single or few hypopigmented or reddish skin lesions with loss of sensation
Diagnosis:
Diagnosis of leprosy is based on clinical examination, skin biopsies, and laboratory tests:
- Clinical examination: Evaluation of skin lesions and symptoms, including loss of sensation and nerve damage.
- Skin biopsies: Microscopic examination of skin tissue samples for the presence of *Mycobacterium leprae*.
- Serological tests: Detection of antibodies specific to *M. leprae*.
Treatment:
Leprosy is curable with multidrug therapy (MDT) recommended by the World Health Organization (WHO). MDT consists of a combination of antibiotics to kill the bacteria and reduce the risk of complications:
- Rifampicin
- Dapsone
- Clofazimine
- Others as appropriate
Treatment duration varies depending on the type of leprosy and may range from 6 months to 2 years or more. Early diagnosis and treatment can prevent disability and promote complete recovery.
Leprosy is a preventable disease, and control efforts focus on early detection and treatment, education about transmission, and reducing social stigma associated with the disease.